Sunday, 1 June 2014

Novartis skin cancer drug shrinks tumors in Phase II trial

ZURICH (Reuters) - An experimental drug from Novartis markedly shrank tumors in patients with advanced basal cell carcinoma, the most common form of skin cancer, according to the results of a mid-stage study published on Sunday.






via Reuters: Health News Read More Here..


Lake forest health and fitness http://ift.tt/1wNCoPC

No comments:

Post a Comment